PRNewswire - November 23, 1999

Med-Design Chief Operating Officer, Michael W. Simpson commented, "This alert from the CDC further confirms the serious nature of this crisis in our health care facilities and should bring an even more rapid conversion to safety needles." Simpson added, "The industry is highly influenced by these safety alerts. In fact, after the 1992 safety alert issued by the FDA regarding the danger of the spread of deadly disease with the use of conventional I.V. Administration Sets, the market was nearly totally converted to safety within 24 months."

The CDC safety alert will now be communicated to hospitals, nursing organizations and physician groups this week. The alert cautions that as many as 800,000 health care workers, including nurses, physicians, laboratory staff and other health care workers are victims of potentially deadly accidental needle sticks each year, with more than 1,000 becoming infected with HIV or liver-destroying hepatitis.

"Too many people see needle stick injuries as a routine part of doing business," said Dr. Linda Rosenstock of the CDC's National Institute for Occupational Safety and Health. "We want to change that view -- it shouldn't be the case."

In addition to this alert by the CDC and the recent mandate from OSHA, 25 states, representing approximately 70% of the health care market, have either passed, are considering or are drafting legislation to mandate the use of safety needles in health care facilities within those states. On the federal level, legislation mandating the use of safety needles in all health care facilities is also being considered in both houses of Congress.

In a nationally televised newscast yesterday, ABC World News Tonight reported that the Centers for Disease Control said that if needles must be used, the CDC recommends needles with safety features such as retractable points.

Med-Design is a leader in the design and development of such retractable safety needle technology, and has developed a full range of safety needle applications to greatly enhance healthcare worker and patient protection. As one of a very limited number of firms focused exclusively on the design and development of safety needles, MDC currently has a portfolio of more than 21 safety needle products covering applications within the important risk areas of blood collection, infusion therapy, insertion and injection. Many industry professionals have recognized these products as being extremely user friendly and cost effective, both important criteria for meeting stringent user requirements while minimizing manufacturing costs.

Forward Looking Statements

This release may contain forward-looking statements, which are included in accordance with the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and accordingly, the cautionary statements contained in Med-Design's Annual Report on form 10-KSB for the year ended December 31, 1998 (See Item I - Business, and Item 6 - Management's Discussion and Analysis of Plan of Operation), and other filings with the Securities and Exchange Commission are incorporated herein by reference. Such forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results and performance in future periods to be materially different from any future results or performance suggested by the forward-looking statements in this release. Such forward-looking statements speak only as of the date of this release. The Company expressly disclaims any obligation to update or revise any forward-looking statements found herein to reflect any changes in Company expectations of results or any change in events.

Med-Design Corporation is a leader in the design and development of retractable safety needle technology. The Company holds numerous U.S. and international patents on safety needle devices that are designed to enable medical workers to efficiently perform a wide range of medical procedures at greatly reduced risk of exposure to accidental needle sticks.

For more information on Med-Design Corporation (via fax and at no cost), call 1-800-PRO-INFO and dial client code "MEDC." If calling from outside the United States, please dial 1-732-544-2850.

SOURCE The Med-Design Corporation

CONTACT: Lawrence Ellis, Chief Financial Officer of The Med-Design Corporation, 805-339-0375; or General Information Steven Canup, Investor- Analyst, Moira Conlon, or Media, Mary Tokita, all of The Financial Relations Board, 310-442-0599, for The Med-Design Corporation/ (MEDC)
991123
PR991123

Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .